Jul 30, 2019 07:17AM Mylan (MYL) PT Raised to $25 at RBC Capital

May 8, 2019 06:57AM Mylan (MYL) PT Lowered to $26 at RBC Capital

Feb 27, 2019 06:57AM Mylan (MYL) PT Lowered to $45 at RBC Capital

Nov 6, 2018 06:45AM Mylan (MYL) PT Lowered to $50 at RBC Capital

Aug 13, 2018 07:24AM RBC Capital Upgrades Mylan (MYL) to Outperform; Numbers Have Bottomed and Sentiment Can Only Improve

Aug 9, 2018 01:04AM Perrigo plans to separate prescription pharma business

May 10, 2018 08:50AM Mylan (MYL) PT Lowered to $42 at RBC Capital

Apr 3, 2018 06:59AM Advair is One of the Biggest Generic Profit Opportunity in Years, RBC Highlights; Mylan (MYL) in Pole Position

Apr 3, 2018 06:10AM Mylan (MYL) PT Raised to $45 at RBC Capital; Positive Near-Term on Stock

Aug 9, 2017 04:56PM Mylan (MYL) PT Lowered to $32 at RBC Capital; Reiterates Sector Perform

Aug 4, 2017 06:21AM Mylan (MYL): Tactical Downside Trade

Jun 5, 2017 06:15PM Drugmaker Perrigo says CEO Hendrickson plans to retire

May 11, 2017 06:18AM Mylan (MYL): Cutting PT, Guidance Will Be Tough To Meet - RBC

Apr 17, 2017 06:07AM Mylan (MYL): Full Year in Question - RBC

Mar 29, 2017 02:27PM RBC Capital Reiterates Sector Perform Rating and $48 PT on Mylan (MYL); 'Uncertainty to 2017 Guidance'

Mar 2, 2017 06:47AM Mylan (MYL) PT Raised to $48 at RBC Capital on Solid 4Q Results, 'Favorable' 2017 Guidance

Mar 1, 2017 10:21AM EpiPen maker Mylan forecasts strong 2017; shares jump

Nov 11, 2016 01:03AM Trump presidency could prove a salve for pharma merger deals

Nov 10, 2016 06:52AM Mylan (MYL): Cutting PT Despite Guidance Reiteration On Generic Visibility Worsening - RBC

Oct 10, 2016 07:24AM Mylan (MYL): Don't Get Too Excited - RBC

Sep 16, 2016 04:52PM Perrigo explores sale of royalties of drug Tysabri: sources

Sep 12, 2016 07:16AM Activist Starboard demands rapid changes at Perrigo

Sep 6, 2016 06:41AM Mylan (MYL): Cutting Ests On Continued Headline Risk - RBC

Feb 11, 2016 11:09AM Mylan (MYL) Shares Look to Stabilize After Pounding on 'Desparate' Meda Deal

Feb 11, 2016 08:05AM RBC Capital Views Mylan's (MYL) Meda Purchase as Desperate - PT to $58

Nov 13, 2015 09:32AM Pre-Open Stock Movers 11/13: (LPCN) (PLNT) (MYL) Higher; (VIPS) (JWN) (FOSL) Lower (more...)

Nov 2, 2015 09:39AM RBC Capital Cuts Price Target on Mylan (MYL) Ahead of PRGO Acquisition Tender deadline

Sep 16, 2015 11:36AM Endo (ENDP) Seen as Attractive Option for Perrigo (PRGO) as Mylan (MYL) Defense - RBC

Nov 26, 2014 09:34AM Pre-Open Stock Movers 11/26: (VEEV) (BLOX) (TASR) Higher; (SDRL) (VNET) (WDAY) Lower (more...)

Aug 8, 2014 10:40AM Notable Analyst Rating Changes 08/08: (ATVI) (ABX) (DK) Upgraded; (MYL) (HIBB) (SSYS) Downgraded

Aug 8, 2014 07:09AM RBC Capital Downgrades Mylan (MYL) to Sector Perform

Jan 6, 2014 05:16PM RBC Capital Starts Mylan (MYL) at Outperform

Aug 2, 2013 10:40AM Notable Analyst Rating Changes 08/02: (MYL) (CTXS) (FLT) Upgraded; (MOS) (GME) (VCLK) Downgraded

Jan 8, 2013 10:31AM Notable Analyst Rating Changes 01/08: (CELG) (MGM) (LUV) Upgraded; (FIO) (DECK) (MYL) Downgraded

Nov 7, 2011 11:17AM Notable Analyst Rating Changes 11/07: (HD) (TOL) (UDR) Upgraded; (ALU) (VRTX) (SD) Downgraded

Oct 11, 2011 10:40AM Notable Analyst Rating Changes 10/11: (NUE) (SFD) (ARO) Upgraded; (COP) (PDLI) (STP) Downgraded

Aug 9, 2010 10:56AM Notable Analyst Rating Changes 08/09: SKH, MYL, BEE, PG Upgraded; PCS, MDT, PMC, CSA Downgraded

Jan 8, 2010 10:51AM Notable Analyst Rating Changes 1/8: HAL, AMAT, JCP, AGU, ESV, RDN, More Upgraded; M, KO, STX, ERIC, WEN, PCS, More Downgraded

Mar 13, 2009 10:16AM David Moenning's Daily State of the Markets: 3/13

Feb 23, 2009 10:31AM David Moenning's Daily State of the Markets 2/23